1. Volume 152, Issue 1, Pages 68-75 (January 2019)
Non-pegylated liposomal doxorubicin (NPLD, Myocet®) + carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trial 
Clémence Romeo, Florence Joly, Isabelle Ray-Coquard, Claude El Kouri, Anne Mercier-Blas, Dominique Berton-Rigaud, Elsa Kalbacher, Oana Cojocarasu, Michel Fabbro, Jacques Cretin, Alain Zannetti, Sophie Abadie-Lacourtoisie, Delphine Mollon, Anne-Claire Hardy-Bessard, Magali Provansal, Emmanuel Blot, Catherine Delbaldo, Anne Lesoin, Gilles Freyer, Benoît You 
Gynecologic Oncology 
Volume 152, Issue 1, Pages (January 2019)
DOI: /j.ygyno
Copyright © 2018 Elsevier Inc. Terms and Conditions

2. Fig. 1 Flow Chart for both phase Ib and phase II steps.
Gynecologic Oncology  , 68-75DOI: ( /j.ygyno )
Copyright © 2018 Elsevier Inc. Terms and Conditions

3. Fig. 2
Progression Free Survival (PFS) – Intention To Treat (ITT) and Per Protocol (PP) populations.
Gynecologic Oncology  , 68-75DOI: ( /j.ygyno )
Copyright © 2018 Elsevier Inc. Terms and Conditions